Cargando…

Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France

We used a mathematical model to evaluate the impact of mass testing in the control of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Under optimistic assumptions, one round of mass testing may reduce daily infections by up to 20–30%. Consequently, very frequent testing would be requir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bosetti, Paolo, Kiem, Cécile Tran, Yazdanpanah, Yazdan, Fontanet, Arnaud, Lina, Bruno, Colizza, Vittoria, Cauchemez, Simon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2021
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791601/ https://www.ncbi.nlm.nih.gov/pubmed/33413741 http://dx.doi.org/10.2807/1560-7917.ES.2020.26.1.2001978

Ejemplares similares

Epidemiology and control of SARS-CoV-2 epidemics in partially vaccinated populations: a modeling study applied to France
por: Bosetti, Paolo, et al.
Publicado: (2022)

Impact of booster vaccination on the control of COVID-19 Delta wave in the context of waning immunity: application to France in the winter 2021/22
por: Bosetti, Paolo, et al.
Publicado: (2022)

Lockdown as a last resort option in case of COVID-19 epidemic rebound: a modelling study
por: Tran Kiem, Cécile, et al.
Publicado: (2021)

Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021
por: Tran Kiem, Cécile, et al.
Publicado: (2021)

Lockdown impact on COVID-19 epidemics in regions across metropolitan France
por: Cauchemez, Simon, et al.
Publicado: (2020)

Projecting the COVID-19 epidemic risk in France for the summer 2021
por: Mazzoli, Mattia, et al.
Publicado: (2021)

Excess cases of influenza-like illnesses synchronous with coronavirus disease (COVID-19) epidemic, France, March 2020
por: Boëlle, Pierre-Yves, et al.
Publicado: (2020)

Education and mental health: good reasons to vaccinate children
por: Cauchemez, Simon, et al.
Publicado: (2021)

Screening and vaccination against COVID-19 to minimise school closure: a modelling study
por: Colosi, Elisabetta, et al.
Publicado: (2022)

SARS-CoV-2 transmission across age groups in France and implications for control
por: Tran Kiem, Cécile, et al.
Publicado: (2021)

A modelling study investigating short and medium-term challenges for COVID-19 vaccination: From prioritisation to the relaxation of measures
por: Tran Kiem, Cécile, et al.
Publicado: (2021)

Highlighting socio-economic constraints on mobility reductions during COVID-19 restrictions in France can inform effective and equitable pandemic response
por: Valdano, Eugenio, et al.
Publicado: (2021)

Modelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and Futuna
por: Brault, Antoine, et al.
Publicado: (2022)

Impact of January 2021 curfew measures on SARS-CoV-2 B.1.1.7 circulation in France
por: Di Domenico, Laura, et al.
Publicado: (2021)

Estimating the burden of SARS-CoV-2 in France
por: Salje, Henrik, et al.
Publicado: (2020)

Characteristics of the delayed respiratory syncytial virus epidemic, 2020/2021, Rhône Loire, France
por: Casalegno, Jean-Sebastien, et al.
Publicado: (2021)

Modeling the impact of national and regional lockdowns on the 2020 spring wave of COVID-19 in France
por: Roux, Jonathan, et al.
Publicado: (2023)

Severe paediatric conditions linked with EV-A71 and EV-D68, France, May to October 2016
por: Antona, Denise, et al.
Publicado: (2016)

Excess all-cause mortality during the first wave of the COVID-19 epidemic in France, March to May 2020
por: Fouillet, Anne, et al.
Publicado: (2020)

Novel coronavirus (2019-nCoV) early-stage importation risk to Europe, January 2020
por: Pullano, Giulia, et al.
Publicado: (2020)

Hepatitis A: an epidemiological survey in blood donors, France 2015 to 2017
por: Gallian, Pierre, et al.
Publicado: (2018)

COVID-19: France grapples with the pragmatics of isolation
por: Atlani-Duault, Laetitia, et al.
Publicado: (2020)

Early underdetected dissemination across countries followed by extensive local transmission propelled the 2022 mpox epidemic
por: Paredes, Miguel I., et al.
Publicado: (2023)

Rebound in community antibiotic consumption after the observed decrease during the COVID-19 pandemic, EU/EEA, 2022
por: Ventura-Gabarró, Cèlia, et al.
Publicado: (2023)

Emergence of enterovirus D68 clade D1, France, August to November 2018
por: Bal, Antonin, et al.
Publicado: (2019)

Impact of lockdown on COVID-19 epidemic in Île-de-France and possible exit strategies
por: Di Domenico, Laura, et al.
Publicado: (2020)

Managing COVID-19 importation risks in a heterogeneous world
por: Cauchemez, Simon, et al.
Publicado: (2021)

Agent-based modelling of reactive vaccination of workplaces and schools against COVID-19
por: Faucher, Benjamin, et al.
Publicado: (2022)

A large-scale outbreak of hand, foot and mouth disease, France, as at 28 September 2021
por: Mirand, Audrey, et al.
Publicado: (2021)

Plateaus, rebounds and the effects of individual behaviours in epidemics
por: Berestycki, Henri, et al.
Publicado: (2021)

A major impact of the influenza seasonal epidemic on intensive care units, Réunion, April to August 2016
por: Filleul, Laurent, et al.
Publicado: (2016)

Two cases of multidrug-resistant Neisseria gonorrhoeae related to travel in south-eastern Asia, France, June 2019
por: Poncin, Thibaut, et al.
Publicado: (2019)

Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021
por: Gaymard, Alexandre, et al.
Publicado: (2021)

Attitudes of healthcare workers towards COVID-19 vaccination: a survey in France and French-speaking parts of Belgium and Canada, 2020
por: Verger, Pierre, et al.
Publicado: (2021)

Assessment of the impact of the extension of vaccination mandates on vaccine coverage after 1 year, France, 2019
por: Lévy-Bruhl, Daniel, et al.
Publicado: (2019)

Autochthonous dengue in mainland France, 2022: geographical extension and incidence increase
por: Cochet, Amandine, et al.
Publicado: (2022)

Evaluating the effect of demographic factors, socioeconomic factors, and risk aversion on mobility during the COVID-19 epidemic in France under lockdown: a population-based study
por: Pullano, Giulia, et al.
Publicado: (2020)

COVID-19 herd immunity: where are we?
por: Fontanet, Arnaud, et al.
Publicado: (2020)

Ceftriaxone-resistant, multidrug-resistant Neisseria gonorrhoeae with a novel mosaic penA-237.001 gene, France, June 2022
por: Berçot, Béatrice, et al.
Publicado: (2022)

Minimising school disruption under high incidence conditions due to the Omicron variant in France, Switzerland, Italy, in January 2022
por: Colosi, Elisabetta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4b7d5ofq6itneeiurdvjvn0n4m